Photon-counting CT (PCCT) technology can reduce the dose on CT lung cancer screening exams to the equivalent of chest x-rays, researchers have reported.
“[Our study found that] semiautomated nodule detection is highly sensitive in [PCCT] x-ray dose scans,” wrote a team led by Bjarne Kerber, MD, of the University Hospital Zürich. The study results were published March 10 in Investigative Radiology.
Reducing radiation dose on CT imaging is key to providing patients with the best care, and PCCT has been shown to help do that. Using PCCT for lung cancer screening shows promise in this regard.
For their study, Kerber’s group evaluated the effect of PCCT dose reduction to x-ray equivalent levels on lung imaging nodule detection, diameter, volume, and density compared to a low-dose reference standard using semiautomated…